The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

Angelos Hatzakis(Athens State University), Harry L.A. Janssen(Erasmus MC), F Roudot-Thoraval(Institut de Veille Sanitaire), Manuel Carballo(International Organization for Migration), Vincent Soriano(Instituto de Salud Carlos III), Elisabeth Delarocque‐Astagneau(Institut de Veille Sanitaire), Patrick Marcellin(Inserm), Mark Thursz(St Mary's Hospital), Gamal Esmat(Cairo University), George Papatheodoridis(National and Kapodistrian University of Athens), Dominique Valla(Inserm), Massimo Colombo(University of Milan), Pierre Van Damme(University of Antwerp), Marco Cavaleri(European Medicines Agency), Rafael Esteban(Universitat Autònoma de Barcelona), Marı́a Buti(Vall d'Hebron Hospital Universitari), Lucas Wiessing(European Monitoring Centre for Drugs and Drug Addiction), Alessandro Zanetti(University of Milan), Daniele Prati(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Geoffrey Dusheiko(UCL Australia), Nadine Y. Piorkowsky(European Federation of Allergy and Airways Diseases Patients Associations), Irene Veldhuijzen(GGD Rotterdam-Rijnmond), Suzanne Wait, Mario Rizzetto(University of Turin), Heiner Wedemeyer(Medizinische Hochschule Hannover), Anna S. Lok(University of Michigan–Ann Arbor), Jordi Bruix(Universitat de Barcelona), David Goldberg(Children's Hospital of Philadelphia), Charles Gore(Medicines Patent Pool), Alojz Peterle(European Parliament), Howard C. Thomas(St Mary's Hospital), Michael P. Manns(Medizinische Hochschule Hannover)
Journal of Viral Hepatitis
August 9, 2011
Cited by 234


Related Papers